A Comparison of the Prognostic Value of Early PSA Test-Based Variables Following External Beam Radiotherapy, With or Without Preceding Androgen Deprivation: Analysis of Data From the TROG 96.01 Randomized Trial

Article ID	Journal	Published Year	Pages	File Type
8230935	International Journal of Radiation OncologyBiologyPhysics	2011	7 Pages	PDF

Abstract

The postradiation nPSA value is the strongest prognostic indicator of all early PSA-based variables. However, its use as a surrogate endpoint needs to take into account its dependence on pretreatment variables and treatment method.

Keywords

Prostate cancer Biochemical failure Androgen deprivation Radiation therapy

Related Topics

Physical Sciences and Engineering Physics and Astronomy Radiation

Preview

A Comparison of the Prognostic Value of Early PSA Test-Based Variables Following External Beam Radiotherapy, With or Without Preceding Androgen Deprivation: Analysis of Data From the TROG 96.01 Randomized Trial

Authors

David S. F.R.A.N.Z.C.R., James W. M.D., F.R.A.N.Z.C.R., David F.R.A.N.Z.C.R., John F.R.A.N.Z.C.R., Chris F.R.A.N.Z.C.R., Nigel A. F.R.A.N.Z.C.R., Gillian F.R.C.R., F.R.A.N.Z.C.R., Martin Ph.D., Allison B.Math., Brett M.D., F.R.A.C. Path, Catherine Ph.D.,